Update on Sexually Transmitted Infections among Persons Living with HIV
|
|
- Susan Wright
- 6 years ago
- Views:
Transcription
1 Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases
2 Abbreviations and note Some abbreviations NG, Neisseria gonorrhoeae CT, Chlamydia trachomatis TP, Treponema pallidum (syphilis) TV, Trichomonas vaginalis HSV, Herpes simplex virus MG, Mycoplasma genitalium Most recommendations based on U.S. Centers for Disease Control and Prevention guidelines
3 Overview Screening for STIs Four clinical cases that cover: Proctitis Genital Ulcers Vaginitis Urethritis
4 I. STI SCREENING
5 The percentage of asymptomaticstis
6 Periodic screening for STIs in sexually active persons living with HIV MMWR 2003;52(RR12) MMWR 2010;59(RR12) Syphilis Annually Everyone Every 3 6 months Consider based on risk factor(s)* Chlamydia and Gonorrhea Annually MSM; Women 25 years-old Annually (or 3 6 months) Consider based on risk factor(s)* Re-screen at 3 months Following treatment Trichomonas Annually Women Re-screen at 3 months Following treatment * history of STI, multiple or anonymous partners, active substance abuse, inconsistent condom use, sex work, partner with any of above, high local prevalence, risky lifechanges, e.g. dissolution of a relationship
7 Prevalence of extragenital sexual behaviors ORAL SEX Oral Sex Males Females Active Oral Passive Oral Active Oral Passive Oral Lifetime 77% 79% 68% 73% ANAL SEX Young MSM: 50% Young heterosexual men and women: 14-49% Last sex 27% 28% 19% 28% Michael RT, et al. Sex in America: A Definitive Survey. Little, Brown and Co. UK Ekstrand M, et al. AIDS 1999; 13 (12): Halperin D, et al. AIDS Patient Care STDs 1999; 13(12);
8 Extragenital NG/CT testing is essential *HIV Clinic with 65% Screening Coverage in 2010 (Unpublished HIV Research Network data) Example clinic: 117 / 175 (67%) cases detected were extragenital < 10% simultaneous positivity at genital sites AIDS Pt Care STDs. 2005;19:495, AIDS Pt Care STDs. 2008;22:947 Among women, ~25% of cases extragenital Sex Transm Dis. 2011;38:783 Opportunity to reduce HIV transmission
9 Extragenital site screening recommendations MMWR 2003;52(RR12) Gonorrhea and Chlamydia: annually (or 3 6 months based on risk*) Rectum Oropharynx Anyone engaged in receptive anal sex Anyone engaged in receptive oral sex for NG CT not recommended, but potentially beneficial, and negligible downside * history of STI, multiple or anonymous partners, active substance abuse, inconsistent condom use, sex work, partner with any of above, high local prevalence, risky life-changes, e.g. dissolution of a relationship Use a nucleic acid test (NAT) if possible! MMWR 2011;60(1):18 Sensitivity for NG: culture ~50% vs. NAT >90% Extragenital NAT s not FDA approved but available with laboratory validation
10 II. CLINICAL CASES
11 Case 1 22 year-old man (CD4 230 / VL 270,000) complains of painful defecation, tenesmus, and blood with wiping. Last sexual encounter, 6 wk ago, involved male and female partners, and included insertive vaginal and receptive rectal intercourse with condom use. Rectal exam notable for tenderness and fecal occult blood test was positive, but no internal or external hemorrhoids or fissures. What next?
12 Proctitis Neisseria gonorrhoeae Chlamydia trachomatis D-K Chlamydia trachomatis L1-L3 [LGV] Treponema pallidum HSV 1 and HSV-2 Ideal Workup NAT for NG/CT Culture or NAT for HSV TP serology Or what is available NG culture, TP serology?
13 Empiric Treatment of Proctitis Drug One (NG) Recommended Ceftriaxone 250mg IM x 1 Alternate Cefixime 400mg PO x 1 Drug Two (NG, CT (D-K and L1-3), TP) Recommended Doxycycline 100mg PO BID x 3 wk Alternate Azithromycin 1g PO qwk x 3 wk Cephalosporin Allergy Consider HSV coverage Azithromycin 2g PO x 1 PLUS Doxycycline 100mg PO BID x 3 wk Valacyclovir 1g PO BID x 7 days MMWR. 2010;59(RR12); MMWR. 2012;61(31)
14 Case 1 Patient: No shots! >> Cefixime 400mg PO x1 given >> Doxycycline 100mg PO q12hr x 3 weeks begun >> NG/CT NAT, HSV culture, syphilis serology sent
15 Case 1 -Two days later NG/CT NAT: NG POS/ CT NEG HSV culture: pending Syphilis treponemal test: NEG Patient improving
16 Do all of the following except... A. Continue doxycycline for 7 days total B. One-week test-of-cure C. Re-screen for NG at 3 mon D. Azithromycin 500mg PO x 1
17 D. Azithromycin 500mg NOT INDICATED A. Doxycyline 7 days Completion of two-drug course for NG NAT sufficient to rule-out CT (including L1-L3) B. One-week Test-of-Cure Now recommended if any alternative regimen is used for NG MMWR. 2012;61(31) Use culture if available C. Re-screen at three months Recommended after any NG, CT, or TV infection MMWR. 2010;59(RR12) D. Azithromycin Not needed if doxycycline given 1000mg is the dose
18 Failure of non-preferred NG regimen Assess re-infection risk Ceftriaxone 250mg IM x 1 AND azithromycin 2gm PO x 1 Every effort to culture Report resistance profile to public health dept Failures of preferred regimen (ceftriaxone plus azithromycin)? Infectious Disease consultation Spectinomycin, gentamicin, ertapenem
19 In vitroresistance in 108 NG isolates in Vietnam, 2011 (Olsen. BMC Infect Dis 2013;13:40) Antimicrobial % Intermediate or Resistant Penicillin, Ciprofloxacin, Tetracycline > 90 Azithromycin 38 Cefixime 1 Ceftriaxone 5 Spectinomycin 0 5% cefixime failure rate in Toronto clinic, 2011 (Allen. JAMA 2013;309(2):163) 9 cases with tests-of-cure, denial of interval sexual activity Cefixime MIC s 0.12 µg/ml 17% Ciprofloxacin resistance in Rio de Janeiro (Uehara. JClinMicrob 2011;49(12):4208)
20 Case 2 33 y.o. woman (CD4 1060, HIV RNA <20) complains of one week of thin, white vaginal discharge. She and her boyfriend recently stopped using condoms in an effort to conceive. She describes receptive vaginal and anal intercourse with only her boyfriend. Scant thin discharge on exam, normal cervix Wet mount normal, ph 7 Which laboratory tests should be performed?
21 Case 2 Diagnostics Vaginal swab for NG/CT NAT or culture(s) Sensitivity of NAT 95-98% Sex Trans Dis 2005;32:725 Vaginal swab for Trichomonas vaginalis NAT or culture MMWR. 2010;59(RR12) Sensitivity of wet mount ~50-70% Sensitivity of culture ~85% Sensitivity of NAT >95% Syphilis serology Rectal swab for NG/CT NAT
22 Trichomonas vaginalis (NAT positive) Syndromes Asymptomatic Vaginitis (vaginal ph usually >4.5) Urethritits First-line therapy Tinidazole 2g PO X1 OR Metronidazole 500mg PO BID X 7 days OR Metronidazole 2g PO X1 Partners in the preceding 60 days must be treated 3-month screening because of high reinfection rates Yearly screening for all sexually-active HIV+ women TV probably increases HIV shedding J Infect Dis. 2001;183:1017
23 Failure to Respond to First Line Consider re-infection Resistance to 5-nitroimidazoles (only class) ~5% of strains have low-level resistance Can be overcome with higher doses Tinidazole vs. metronidazole Longer half-life Higher tissue concentrations MIC s to tinidazole lower If patient fails Rx with metronidazole 2g PO X1 Tinidazole 2 g PO X1 OR Metronidazole 500mg PO BID X 7d If patient has failed one of the above Metronidazole 2g PO QD X 5d OR Tinidazole 2g PO QD X 5d
24 Case 3 36 y.o. man (CD4 535, HIV RNA 1370), complains of scant, white penile discharge for 4 months. Male partners, intermittent condom use. Exam unremarkable. One month ago: UA: WBC / HPF (No nitrates, epi s, RBC) Urine NG/CT NAT NEG Urine culture NEG
25 What is the first-line empiric therapy? A. Gentamicin 240mg IM x 1 B. Trim/sulfa (800/160) PO q12 x 3 days C. Azithromycin 1000mg PO x 1 D. Metronidazole 2g PO x 1
26 Empiric therapy for non-gonococcal urethritis A. Gentamicin 240mg IM x 1 Possible in cephalosporin-resistant NG, but nor currently recommended B. Trim / sulfa (800/160) PO q12 x 3 days Bacterial cystitis unlikely with negative culture C. Azithromycin 1000mg PO x 1 First line empiric therapy MMWR. 2010;59(RR12) Azithromycin 1000mg PO x1 OR Doxycycline 100mg PO q12 x 7 days D. Metronidazole 2g PO x 1 Second-line in empiric algorithm for non-gonoccocal urethritis (Trichomonas coverage)
27 Non-Gonococcal urethritis (NGU) Confirm urethritis(any of the following) Purulent discharge on exam 5 WBC / HPF on urethral Gram stain 10 WBC on urinalysis Common etiologies Clin Infect Dis. 2013; 56:934 Chlamydia trachomatis (25% cases) Mycoplasma genitalium (15%) Trichomonas vaginalis (2-3%, less common MSM) Ureaplasma urealyticum (25%, controversial) Idiopathic (40%) Uncommon or underdiagnosed: HSV, enterobacteriaceae, Haemophilus, Staphylococcus saprophyticus, adenovirus
28 Case 3 -Diagnostics Repeat urinalysis Urine NAT for M. genitalium (if available) No US FDA approved assays Urine sensitivity (men) ~90% Vaginal swab sensitivity ~85% J Clin Microbiol 2006;44:3306, J Clin Microbiol 2011;49:1990, Sex Trans Dis 2004;31:499 Urine NAT for NG/CT (repeat) Syphilis serology, oral and rectal NG/CT NAT (screening) Consider: Urine NAT or urethral culture for T. vaginalis, urethral swab for HSV culture or NAT
29 Case 3 M. genitaliumurethritis Azithromycin 1gm given Test results UA: WBC / HPF Urine, rectal, oral NG/CT NATs NEG RPR NEG Urine M. genitaliumnat: POS One-month phone call Slightly better Return visit scheduled
30 NGU First-line Treatment Failure This MG case Assess reinfection risk First-line MG agents efficacy Azithromycin 40-75% Doxycycline 30-50% Clin Infect Dis. 2013; 56:934 Second-line: moxifloxacin 400mg PO qday x 7d PLOS One. 2008;3(11):e3618 Int J STD AIDS. 2008;19:676 Consider TV urine assay HSV urethral swab assay Without diagnostics Assess reinfection risk
31 Case 4 41 year-old man presents with 8 weeks of a painful perianal ulcer. Undetectable HIV RNA for 3 years, but CD4 fallen from 800 to 40 amidst chemotherapy for lymphoma Valacyclovir 1000mg TID for 7 weeks Cultures 6 wk ago and 3 wk ago: HSV-2 Exam: 6cm slightly-exudative perianal ulcer with welldefined borders, extending from anal verge What next?
32 Case 4 Consider co-existing pathology (purulent bacterial superinfection, syphilis, cancer) Acyclovir resistance Thymidine kinase mutations >95% of instances Assay requires culture, 2-3 week turn around Long-term HSV suppression with acyclovir PREVENTS acyclovir resistance J Infect Dis. 2007;196:266 Only test if clinical failure NEJM. 1984;310(24):1545
33 Agents for acyclovir-resistant HSV Topical Imiquimod Immune modulator 5% cream QOD for 3 weeks Locally irritative Cidofovir 1% gel, compounding pharmacy, QD for 5 days Intravenous Oral Foscarnet Cidofovir q8hr IV for ~3 weeks, fluids and monitoring Qwk IV, less tolerable than foscarnet Thalidomide anecdotes in hypertrophic disease Sex Transm Infect. 2011;87:29 J Infect Dis. 1997;176:892 FDA approved Clin Infect Dis. 2007;44:e96
34 Major take-home points Screening for TP / NG / CT / TV At least annually for many sexually-active patients Extragenital sites important (if tests available) 3-month screen after any treatment Proctitis: ceftriaxone 250mg + doxy (3 weeks) Non-preferred NG regimen: 1 week test-ofcure Non-gonoccocal urethritis treatment algorithm: include moxifloxacin if previous meds fail Acyclovir-resistant HSV: imiquimod
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationClinical Cases from the STD Clinical Consultation Network
Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850 STD Clinical Consultation Network (STDCCN) Developed
More informationProfessor Jonathan Ross
SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationSEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS
SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS Sarah Garwood MD, Assistant Professor of Pediatrics, Washington University Elizabeth Fox MD, Pediatric Resident, St Louis Children s Hospital STDS IN ADOLESCENTS
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSTI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research
Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationSexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa
Sexually Transmitted Infections Angela Farrell MD Dept of Family Medicine University of Iowa Objectives Review taking a sexual history Discuss screening, diagnosis, and management of chlamydia, gonorrhea,
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationTimby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
More informationAdvances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol
Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing
More informationStephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationUpdate on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationDrugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal
Drugs for UTIs and STDs Dr.Vishaal Bhat Associate Professor MMMC Manipal Classification of UTI s Clinical: Asymptomatic (98%) Symptomatic (1-2%) Anatomical: Lower tract dis: asymptomatic bacteriuria and
More informationChancroid Table of Contents
Subsection: Chancroid Page 1 of 8 Chancroid Table of Contents Chancroid Fact Sheet Subsection: Chancroid Page 2 of 8 Chancroid (Haemophilus ducreyi) Overview (1,2) For a more complete description of chancroid,
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More informationThe (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview
The (likely) New 2010 CDC STD Treatment Guidelines http://www.cdc.gov/std/treatment Deborah Cohan, MD, MPH University of California, San Francisco San Francisco General Hospital cohand@obgyn.ucsf.edu I
More informationDisclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationSTD UPDATE 2017 FSACOFP CONVENTION
STD UPDATE 2017 FSACOFP CONVENTION L. Michael Waters, Jr, DO Adjunct Clinical Assistant Professor of Family Medicine LECOM-Bradenton Clinical Assistant Professor of Family Medicine PCOM- Georgia DISCLOSURES
More informationSexually Transmitted Diseases
Table of content Sexually Transmitted Diseases Judith A. Lightfoot DO, FACOI Update on the prevalence of STD s in the US Which populations are greatly affected? Should we be alarmed? How does this affect
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More informationMYCOPLASMA GENITALIUM A PRACTICAL GUIDE
MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More informationSexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationSay Ahhh!, STDs in Maine. Emer Smith, Maine CDC,
Say Ahhh!, STDs in Maine Emer Smith, Maine CDC, emer.smith@maine.gov Say AHHH! : STDs in Maine Emer S. Smith, MPH Maine Center for Disease Control & Prevention HIV, STD, & Viral Hepatitis Program April
More informationClinical Education Initiative ADOLESCENTS AND STDS: CASE STUDIES. Tara Babu, MD
Clinical Education Initiative Support@ceitraining.org ADOLESCENTS AND STDS: CASE STUDIES Tara Babu, MD 2/16/2017 Adolescents and STDs: Case Studies [video transcript] 00:00:08 - Hello, my name is Tia Babu
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationSexually Transmitted Infection Treatment and HIV Prevention
Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.
More informationPerspective Sexually Transmitted Infections and HIV: Diagnosis and Treatment
Sexually Transmitted Infections and HIV Volume 20 Issue 1 April/May 2012 Perspective Sexually Transmitted Infections and HIV: Diagnosis and Treatment Accurate assessment, diagnosis, and treatment of sexually
More informationExtra-genital STIs: An update. Luis F. Barroso, M.D. Associate Professor Wake Forest Baptist Health
Extra-genital STIs: An update Luis F. Barroso, M.D. Associate Professor Wake Forest Baptist Health Grant Support: NIH Disclosure: Off-Label Disclosure This presentation will include discussion of the following
More informationOAML Guideline on the Investigation of Genital Tract Infections November, 2015
OAML Guideline on the Investigation of Genital Tract Infections November, 2015 1. Purpose The purpose of this guideline is to provide ordering clinicians with a clear and concise reference for the investigation
More informationClinical Education Initiative URETHRITIS. Elizabeth Asiago-Reddy, MD
Clinical Education Initiative Support@ceitraining.org URETHRITIS Elizabeth Asiago-Reddy, MD 3/13/2017 Urethritis [video transcript] 00:00:07 - [Elizabeth] Thanks so much for having me and I'm sorry for
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL
DISCLOSURE PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Dr. Feller does not have any actual or potential conflicts of interest to disclose and will not be discussing
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More informationWhat Bugs You? A Sexually Transmitted Infection Review
What Bugs You? A Sexually Transmitted Infection Review KATIE DESIMONE, PHARM.D. Disclosures I have no financial affiliations with any of the products or therapies discussed in this presentation Objectives
More information10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL
PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES Jade Feller, PharmD PGY-1 Pharmacy Resident Iowa City Veterans Affairs Health Care System November 13, 2018 DISCLOSURE
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY
MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationSTIs in Primary Care. Dr Eleanor Draeger 19 th January 2016
STIs in Primary Care Dr Eleanor Draeger 19 th January 2016 Poli=cs! 2012! Health and Social Care act! Sexual Health commissioning moved to local authority! 2015! 200 million cuts to public health! 40%
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More information20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5. Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH
20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5 Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH The approach to developing quality indicators for vulvovaginitis and sexually transmitted diseases
More informationREPRODUCTIVE TRACT INFECTIONS
REPRODUCTIVE TRACT INFECTIONS State-of-the-Art 02.10.1998 Dr Saloney Nazeer Department of Gynaecology & Obstetrics Geneva University Hospital CLASSIFICATION OF RTIs STDs Non-STDs - infections which result
More information2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017
Sexually Transmitted Diseases in Children: Is it Abuse? Judy Guinn, MD WI CAN Educational Series February 17, 2017 Disclosure Information for: Judy Guinn, MD Sexually Transmitted Diseases in Children:
More informationTrends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
More informationEdward W. Hook, III, M.D.
Challenging Cases Edward W. Hook III M.D. Professor and Director Division of Infectious Diseases University of Alabama at Birmingham And PI, Alabama/North Carolina STD PTC Edward W. Hook, III, M.D. Grant/Research
More informationDisclosure Information Julie Stoltey, MD MPH
Courtesy CDC Public Health Image Library The New Yorker 2012 2016 Update on Testing, Treatment, and Gonorrhea Resistance Julie Stoltey, MD, MPH STD Control Branch-California Dept. of Public Health Assistant
More informationSTD Prevention Among Youth
STD Prevention Among Youth Jody Pierce Glover New Beginnings Emer S. Smith, MPH Maine Center for Disease Control & Prevention In Today s Talk... Maine Learning Results: Education Content Areas Health Behaviors
More informationTreatment resistant STIs relevant to MSM
Treatment resistant STIs relevant to MSM David A. Lewis FRCP (UK) PhD Centre for HIV and STIs National Institute for Communicable Diseases (NHLS) Johannesburg, South Africa Regional Director, IUSTI Africa
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationTO DECREASE THE CHANCE OF GETTING
POST ASSAULT MEDICATIONS Terri Stewart RN Naomi Sugar MD TO DECREASE THE CHANCE OF GETTING Pregnant STDs Chlamydia Gonorrhea Trichomonas Hep B HIV EMERGENCY CONTRACEPTION Plan B Levonorgestrel PLAN B Plan
More informationClinical Guidelines Update (aka Know Your NAATs)
Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz
More informationHOT OFF THE PRESS! R.
STI Update 2016: New CDC Treatment Guidelines Focus on the Female HOT OFF THE PRESS! R. Mimi Secor, DNP, FNP-BC, FAANP Onset, Massachusetts Mimi Secor, DNP, FNP-BC, FAANP Nurse Practitioner for 40 years
More informationExtragenital Gonorrhea and Chlamydia among MSM
Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org
More informationSTIs. Sexually Transmitted Infections. Kimberly A. Workowski, MD, FACP, FIDSA Professor of Medicine Emory University Atlanta, Georgia
Sexually Transmitted Infections Kimberly A. Workowski, MD, FACP, FIDSA Professor of Medicine Emory University Atlanta, Georgia FORMATTED: 11/17/15 Learning Objectives After attending this presentation,
More informationSexually transmitted infections
Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted
More informationSexually Transmitted Infections
Sexually Transmitted Infections Christine Hogan M.D. Sexually Transmitted Pathogens Bacteria Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma genitalium Ureaplasma urealyticum Treponema pallidum
More informationManagement of NGU (Non-gonococcal urethritis)
Management of NGU (Non-gonococcal urethritis) First line Doxycycline 100mg po bd for 7 days (contra-indicated in pregnancy) Alternative regimens Azithromycin 1G po stat Azithromycin 500mg po stat, then
More informationWhat s Going On Down There? Prevalent Sexually Transmitted Infections in Adolescents & Young Adults with HIV
What s Going On Down There? Prevalent Sexually Transmitted Infections in Adolescents & Young Adults with HIV Carla London, DNP, CFNP St Jude Children s Research Hospital November 7, 2018 Conflicts and
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationSexually Transmitted Infections in the ER. Sahand Ensafi, CCPA University Health Network
Sexually Transmitted Infections in the ER Sahand Ensafi, CCPA University Health Network WARNING This presentation will contain numerous grotesque images of genitalia. Viewer discretion is advised. No disclosures
More information2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE
2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Clinical Professor of Pediatrics, SUNY at Buffalo School
More informationCHAPTER 26 - Microbial Diseases of the Urinary and Reproductive System
CHAPTER 26 - Microbial Diseases of the Urinary and Reproductive System Introduction The urinary system regulates the chemical composition of the blood and excretes nitrogenous waste. The reproductive system
More information6. Gonococcal antimicrobial susceptibility
6. Gonococcal antimicrobial susceptibility Key points Gonococcal AMR continues to increase worldwide and could lead to a pandemic of extensively drug-resistant (XDR) N. gonorrhoeae with serious public
More informationThe Synergy between HIV and other STIs
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS The Synergy between HIV and other STIs Alberto Matteelli Brescia University Sexual Transmission
More informationWelcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.
Welcome to: Coding Scenarios for STD Clinic Visits We will begin in a few minutes. There will be no sound until the webinar starts. Welcome to: Coding Scenarios for STD Clinic Visits You are using audio
More informationChlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationGAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016
GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know
More informationSyphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
More information29/09/2017. STI treatment guidelines. Rationale. WHO STI Guidelines. STI Treatment 2016 Guidelines. STI guidelines: Prevention, Management and Control
29/09/2017 1 3 t h ESC Se min ar, Sain t-p e te rsb u rg, 1 3 Se p temb e r 20 17 Declaration of interest STI Treatment 2016 Guidelines Conflict of interest We declare that I have no commercial or financial
More informationSexually Transmitted Infections. Dr. Doug McGhee Victoria STI Clinic Dr. Jennifer Ross Island Sexual Health Society
Sexually Transmitted Infections Dr. Doug McGhee Victoria STI Clinic Dr. Jennifer Ross Island Sexual Health Society ISHS vs STI Clinic Island Sexual Health Society Non-profit society Contraception, IUD,
More informationSEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)
SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5) BACTERIAL VAGINOSIS 1 clindamycin cream 2 Cleocin Vaginal Cream 2% vaginal cream Adults: 1 applicatorful at bedtime for 7 days metronidazole
More informationScreening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016
Screening & Treating Chlamydia in Primary Care Wednesday, September 21, 2016 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary
More informationSexually Transmitted Infections: New Tests, New Guidelines
Sexually Transmitted Infections: New Tests, New Guidelines Michael S. Policar, MD, MPH UCSF Ob, Gyn, and Reproductive Sciences No disclosures for this lecture Value of STI Screening and Testing Benefits
More information